Form D · Biotechnology
Rho Pharmaceuticals, LLC
Glen Mills, PA · CIK 0001756480
Offering snapshot reported Dec 18, 2018 · SEC filing
- Reported sold
- $2.33M Offering amount: $2.33M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 6, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 18, 2018 | Initial | $2,331,250 | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-328248
Includes conversion of certain indebtedness
Source: Form D, filed Dec 18, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Kevin J. O'neill | Director, Executive |
| Hitha Palepu | Director, Executive |
| Nagesh Palepu | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
6 Bethel Road
Glen Mills, PA, 19342
Glen Mills, PA, 19342